GlassScriptPhysician profile
Joey Sessums
NPI 1316054976
$1,596.58
in general payments reported to CMS, 2019-2025
20 companies · $83.73 in 2025
The $83.73 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $370 · 2020: $243 · 2021: $303 · 2022: $178 · 2023: $286 · 2024: $132 · 2025: $83.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $502.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $501.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $361.86 | 2020-2023 | Liletta |
| Amgen INC. | $212.98 | 2019-2025 | Evenity, Prolia |
| Boston Scientific Corporation | $173.29 | 2019 | |
| Pfizer INC. | $165.47 | 2019-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $113.41 | 2020-2022 | |
| Intuitive Surgical, INC. | $112.55 | 2019 | |
| Astellas Pharma US INC | $75.15 | 2022-2024 | Veozah, Myrbetriq |
| Shield Therapeutics INC | $69.07 | 2023-2025 | Accrufer |
| Hologic Sales and Service, LLC | $50.30 | 2023-2025 | Novasure, Myosure Tissue Removal Device |
| Medtronic, INC. | $41.71 | 2023 | Sonicision |
| Daiichi Sankyo INC. | $36.04 | 2021 | |
| Sumitomo Pharma America, INC. | $32.72 | 2023-2024 | Gemtesa, Myfembree |
| Radius Health, INC. | $30.97 | 2020 | |
| Organon LLC | $29.24 | 2022-2023 | Nexplanon |
| Merck Sharp & Dohme LLC | $27.87 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $15.36 | 2024 | Slynd |
| Minerva Surgical, INC | $13.32 | 2019 | |
| Lupin INC. | $12.95 | 2020 | |
| Mayne Pharma Commercial LLC | $11.21 | 2024 | |
| Evofem Biosciences, INC. | $11.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joey Sessums listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.